Advanced Medical Concepts PSC

1. Bayer HealthCare Pharmaceuticals Inc. $77,948 28 payments
2. Sumitomo Pharma America, Inc. $53,976 24 payments
3. AbbVie, Inc. $38,558 25 payments
4. Organon LLC $36,707 21 payments
5. Alnylam Pharmaceuticals Inc. $15,392 115 payments

1. Study Specific Exhibit for Protocol # 17530Study Specific Exhibit to Investigator/Institution Agreement ("Agreement") between BayerHealthCare Pharmaceuticals Inc. and Advanced Medical Concepts PSC ("Investigative Siteand/or Institution") dated the 29th October 2015 $49,840 16 payments
2. A Phase 3, Single-Arm, Open-Label Study to Evaluate the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are 18 to 50 Years of Age and at Risk for Pregnancy $34,335 12 payments
3. Study Specific Exhibit to Investigator/Institution Agreement (Agreement) between BayerHealthCare Pharmaceuticals Inc. and Advanced Medical Concepts PSC (Investigative Siteand/or Institution) dated the 29th October 2015 $28,108 12 payments
4. Efficacy and Safety of Nexplanon 36 to 60 Months Post Insertion $22,930 12 payments
5. A Phase 3b Study to Evaluate the Safety and Efficacy of Elagolix in Combination with Combined Oral Contraceptives in Premenopausal Women with Documented Endometriosis and Associated Moderate to Severe Pain $15,261 6 payments
6. A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension (KARDIA-1) $14,612 94 payments
7. 8415-060 $13,777 9 payments
8. A Phase 3 Singlearm Openlabel Study to Evaluate the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids Or Endometriosis Who Are 18 to 50 Years of Age and at Risk for Pregnancy $10,641 11 payments
9. A Phase 3, Single-Arm, Open-Label Study to Evaluate the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are 18 to 50 Years of Age and at Risk for Pregnancy $9,000 1 payment
10. Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsulesx2FTablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain $7,139 10 payments

1. Patient care $36,707 21 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.